A recent study found that the majority of patients who suffered from long COVID during a time when vaccines and antiviral treatments were widely available were vaccinated.
Although definitions of long COVID differ, the Centers for Disease Control and Prevention broadly defines long COVID as "Signs, symptoms, and conditions that continue to develop after acute COVID-19 infection" that can last for "Weeks, months, or years." The term "Long COVID" also includes post-acute sequelae of SARS-CoV-2 infection, long-haul COVID, and post-acute COVID-19.
Nearly 7 percent of U.S. adults surveyed by the CDC in 2022 said they've experienced long COVID. Although U.S. regulatory agencies claim vaccinating against COVID-19 can reduce the risk of developing long COVID, the current paper did not find a significant link between the presence of comorbidities or infection severity and the emergence of long COVID symptoms.
Some research suggests long COVID may be caused by an immune overreaction to the SARS-CoV-2 spike protein that COVID-19 vaccines use to induce antibodies and that vaccination causes some people to generate a second round of antibodies that target the first.
In a February 2023 study published in the Journal of Medical Virology, researchers analyzed the levels of spike protein and viral RNA in patients hospitalized for COVID-19 with and without long COVID. They found that spike protein and viral RNA were more likely to be present in patients with long COVID. In an August 2023 study published in the International Journal of Infectious Diseases, researchers found the risk of long COVID was lower in those who had previous SARS-CoV-2 infection, and the risk of getting long COVID did not differ by vaccination status.
Researchers found that unvaccinated people infected with omicron had the lowest risk of long COVID. In a 2023 study in the European Review for Medical and Pharmacological Sciences, researchers studied the serum of 81 individuals with long COVID. They found viral spike protein in one patient after the infection had cleared despite having a negative COVID-19 test, and vaccine spike protein in two patients two months after vaccination.
In a December 2022 study published in PLoS One, researchers found patients were more likely to experience long COVID if they had preexisting medical conditions, a higher number of symptoms during the acute phase of COVID-19 illness, if their infection was more severe or resulted in hospitalization, or if they had received two doses of a COVID-19 vaccine.
No comments:
Post a Comment